health care reform

Research in Review

Insurance Expansion Improves Resection Rates Among Patients with Colorectal Cancer

12/13/2016

JCP Editors

The implementation of health care reform in Massachusetts increased surgical resection rates for colorectal cancer and decreased the likelihood of emergent resection, suggesting that insurance expansion may improve...

The...

12/13/2016

Journal of Clinical Pathways

Research in Review

NCCN Responds to Study Findings on Financial Conflicts of Interest

11/04/2016

JCP Editors

The National Comprehensive Cancer Network (NCCN) agreed that ongoing monitoring and research regarding financial conflicts of interest (COIs) at the interface of academia, medicine, and industry is critical,...

The...

11/04/2016

Journal of Clinical Pathways

Clinical Pathways GPS

The Future of Clinical Pathways: The Potential Impact of the Presidential Election

10/12/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

Although the topic of health care will continue to be a political one, the continued growth of public health care spending suggests that the government will need to continue its shift toward improving the value of...

...

10/12/2016

Journal of Clinical Pathways

Research in Review

Process for Reimbursing Off-Label Cancer Drug Use Questioned

09/01/2016

JCP Editors

Off-label drug use, which is widely practiced in oncology care, accounted for $5 billion in cancer drug costs in 2010. Now a team of researchers is recommending an overhaul of the process that determines which cancer...

...

09/01/2016

Journal of Clinical Pathways

Research in Review

Advertising Directly to Patients Dangerous, Suggests New Editorial

08/20/2016

JCP Editors

Cancer-related, direct-to-consumer advertising (CR-DTCA) has the potential to promote misconceptions about the efficacy and toxic effects of new therapeutics, which could be detrimental to patients and the...

...

08/20/2016

Journal of Clinical Pathways

Interview

Reducing Waste in Oncology Drug Use

06/20/2016

  According to a recent report, prescription drug costs rose by more than 12% in 2014 and are expected to continue to rise by more than 7% through 2018.1 In addition, a study of the out-of-pocket costs...

...

06/20/2016

Journal of Clinical Pathways

Research in Review

Bundled Payments Model Utilizing Clinical Pathways a Success for Hip and Knee Replacements

06/20/2016

JCP Editors

A Bundled Payments for Care Improvement model developed at New York University Langone Medical Center (NYULMC), New York City, NY, was successful at improving institutional efficiency and providing more value...

...

06/20/2016

Journal of Clinical Pathways

MACRA Town Hall: Effects on Your Medicare Reimbursement

06/06/2016

JCP Editors

At the “MACRA Town Hall: Effects on your Medicare Reimbursement,” session, Blase Polite, MD, MPP, University of Chicago, Illinois described MACRA using three key adjectives: personal, immediate, and certain. First,...

At the...

06/06/2016

Journal of Clinical Pathways

Counterpoint

Keeping Cures on the Shelf

05/06/2016

George Dahlman

Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...

...

05/06/2016

Journal of Clinical Pathways

Counterpoint

To Increase Innovation and Make Drugs More Affordable, Deregulate

10/27/2015

David R. Henderson, PhD

Charles L. Hooper, MS

Are there ways to make drugs more affordable without reducing the incentive to innovate? Dr. Owens makes two principal claims with which we agree. Any dialogue about the rising cost of cancer drugs must, as the...

Are...

10/27/2015

Journal of Clinical Pathways